Literature DB >> 21472681

Overexpression of GRP78 and GRP94 is involved in colorectal carcinogenesis.

Hiroyuki Takahashi1, Jian-ping Wang, Hua-chuan Zheng, Shinji Masuda, Yasuo Takano.   

Abstract

Glucose-related proteins (GRPs) are ubiquitously expressed in the endoplasmic reticulum and assist in protein folding and assembly, consequently considered to be molecular chaperones. GRP78 and GRP94 expression was induced by glucose starvation and up-regulated in samples taken from several different malignant tissues. To clarify the roles of both molecules in tumorigenesis and progression of colorectal carcinomas, immunohistochemistry (IHC) was performed on tissue microarrays containing colorectal carcinomas, adenomas and the non-neoplastic mucosa (NNM) using antibodies against GRP78 and GRP94. Their expression was correlated with the clinicopathological parameters of carcinomas. Both proteins were also studied in colorectal carcinoma cell lines (DLD-1, HCT-15, SW480 and WiDr) by IHC and Western blot. There was a gradually increased GRP78 expression from colorectal NNMs, carcinomas, to low-grade and high-grade adenomas (P<0.05), while up-regulated GRP94 expression from NNM, low-grade adenoma, high-grade adenoma, to carcinoma (P<0.05). The expression was similar in all the carcinoma cell lines. GRP78 expression was negatively correlated with lymphatic invasion or low GRP94 expression of the carcinomas (P<0.05), while there was no correlation of GRP94 expression with other parameters of carcinomas (P>0.05). Multivariate analysis showed that venous invasion, lymph node metastasis and UICC staging (P<0.05), but not age, sex, tumor size, differentiation, depth of invasion, lymphatic invasion, GRP78 and GRP94 expression (P>0.05), were independent prognostic factors for carcinomas. It is suggested that up-regulated expression of GRP78 and GRP94 could possibly be involved in the pathogenesis of colorectal carcinomas.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21472681     DOI: 10.14670/HH-26.663

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  24 in total

1.  A proteomic approach to identification of plutonium-binding proteins in mammalian cells.

Authors:  Baikuntha P Aryal; Tatjana Paunesku; Gayle E Woloschak; Chuan He; Mark P Jensen
Journal:  J Proteomics       Date:  2011-12-03       Impact factor: 4.044

2.  Concomitant high expression of ERα36, GRP78 and GRP94 is associated with aggressive papillary thyroid cancer behavior.

Authors:  Yu-Jie Dai; Yi-Bo Qiu; Rong Jiang; Man Xu; Ling-Yao Liao; George G Chen; Zhi-Min Liu
Journal:  Cell Oncol (Dordr)       Date:  2018-01-24       Impact factor: 6.730

3.  Differential expression of HSP90 isoforms and their correlations with clinicopathologic factors in patients with colorectal cancer.

Authors:  Kisu Kim; Hyoun Wook Lee; Eun Hee Lee; Moon-Il Park; Jae Seok Lee; Mee-Seon Kim; Kyungeun Kim; Mee Sook Roh; Min Gyoung Pak; Ji Eun Oh; Kwang Min Kim; Jung Won Lee; Tae Gyu Kim; Hyun-Yeol Nam
Journal:  Int J Clin Exp Pathol       Date:  2019-03-01

4.  Glucose-regulated protein 78 (GRP78) regulates colon cancer metastasis through EMT biomarkers and the NRF-2/HO-1 pathway.

Authors:  Yu-Jia Chang; Wei-Yu Chen; Chien-Yu Huang; Hui-Hsiung Liu; Po-Li Wei
Journal:  Tumour Biol       Date:  2014-11-28

5.  HSP90B1 overexpression predicts poor prognosis in NSCLC patients.

Authors:  YiRong Xu; ZhenWen Chen; GuangHeng Zhang; YanFeng Xi; RuiFang Sun; XiaoGang Wang; WenYan Wang; Fei Chai; XiongFeng Li
Journal:  Tumour Biol       Date:  2016-09-06

6.  The pathobiological features of gastrointestinal cancers (Review).

Authors:  Xue Yang; Yasuo Takano; Hua-Chuan Zheng
Journal:  Oncol Lett       Date:  2012-03-01       Impact factor: 2.967

7.  Monoclonal antibody against cell surface GRP78 as a novel agent in suppressing PI3K/AKT signaling, tumor growth, and metastasis.

Authors:  Ren Liu; Xiuqing Li; Wenming Gao; Yue Zhou; Shiuan Wey; Satyajit K Mitra; Valery Krasnoperov; Dezheng Dong; Shuanglong Liu; Dan Li; Genyuan Zhu; Stan Louie; Peter S Conti; Zibo Li; Amy S Lee; Parkash S Gill
Journal:  Clin Cancer Res       Date:  2013-09-18       Impact factor: 12.531

8.  Expression of glucose-regulated protein 78 as prognostic biomarkers for triple-negative breast cancer.

Authors:  Chenlian Yang; Zhiwei Zhang; Yutian Zou; Guanfeng Gao; Lingrui Liu; Haifan Xu; Feng Liu
Journal:  Histol Histopathol       Date:  2019-11-19       Impact factor: 2.303

9.  Colon cancer cells expressing cell surface GRP78 as a marker for reduced tumorigenicity.

Authors:  Britta Hardy; Annat Raiter; Maxim Yakimov; Alexander Vilkin; Yaron Niv
Journal:  Cell Oncol (Dordr)       Date:  2012-09-04       Impact factor: 6.730

10.  Triptolide activates unfolded protein response leading to chronic ER stress in pancreatic cancer cells.

Authors:  Nameeta Mujumdar; Sulagna Banerjee; Zhiyu Chen; Veena Sangwan; Rohit Chugh; Vikas Dudeja; Masato Yamamoto; Selwyn M Vickers; Ashok K Saluja
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-04-03       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.